Evidence map›Paper›PMID 40956094›Full record

ArticleMicrobiology spectrum2025

Profiling bile acids in the stools of humans and animal models of cystic fibrosis.

Melissa M Carmichael, Rebecca A Valls, Shannon Soucy, Julie Sanville, Juliette Madan, Sarvesh V Surve, Mark S Sundrud, George A O'Toole

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Melissa M Carmichael *Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
Rebecca A Valls *Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
Shannon SoucyDepartment of Biomedical Data Science, Geisel School of Medicine, Hanover, New Hampshire, USA.
Julie SanvilleDepartment of Pediatrics, Dartmouth Health, Lebanon, New Hampshire, USA.
Juliette MadanDepartment of Pediatrics, Dartmouth Health, Lebanon, New Hampshire, USA.
Sarvesh V SurveDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
Mark S SundrudDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
George A O'TooleDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.ORCID 0000-0002-2861-4392

Funding

Zhao - Proj 2P20GM130454 · NIGMS · DARTMOUTH COLLEGE · PI Chengxiang Qiu · 2019 to 2026
$27.2M
Translational Research CoreP30DK117469 · NIDDK · DARTMOUTH COLLEGE · PI DEBORAH A HOGAN · 2018 to 2026
$13.9M
Nuclear Receptor Control of T Cell Function in Discrete Intestinal MicroenvironmentsR01AI164772 · NIAID · UNIVERSITY OF FLORIDA · PI SUNDRUD, MARK SCOTT, WEAVER, CASEY T · 2021 to 2025
$4.5M
Nuclear Receptor Networks in Mucosal Immune RegulationU01AI163063 · NIAID · UNIVERSITY OF FLORIDA · PI PIPKIN, MATTHEW EUGENE, SUNDRUD, MARK SCOTT · 2021 to 2025
$2.2M
Dartmouth Cystic Fibrosis Training ProgramT32HL134598 · NHLBI · DARTMOUTH COLLEGE · PI George A. O'Toole · 2017 to 2026
$1.7M
NATIONAL FERRET RESOURCE AND RESEARCH CENTER ON LUNG DISEASE75N92024C00008 · NHLBI · UNIVERSITY OF IOWA · PI BOYLE, JESSICA · 2024 to 2024
$1.7M
Arsenic, the Microbiome & Health Outcomes: Mechanisms to Methods of InterventionR01ES033988 · NIEHS · DARTMOUTH COLLEGE · PI George A. O'Toole · 2023 to 2026
$1.6M
Cystic Fibrosis Foundation 05912G223NHLBI NIH HHS 75N92024C00008NHLBI NIH HHS T32 HL134598NIAID NIH HHS R01 AI164772NIAID NIH HHS U01 AI163063NIDDK NIH HHS P30 DK117469NIEHS NIH HHS R01 ES033988NIGMS NIH HHS P20 GM130454NIH HHS ES 033988-01A1NIH HHS P20-GM130454NIH HHS R01AI164772, U01AI163063, P30DK117469NIH HHS T32HL134598
6 · The paper itself

Abstract

Cystic fibrosis (CF) is associated with aberrant bile acid (BA) metabolism. As little is known about BA in children with CF (cwCF), we performed both comprehensive ( IMPORTANCE: Changes in the abundance and/or composition of intestinal BAs may contribute to dysbiosis and altered gastrointestinal physiology in CF. Here, we report shifts in select fecal BA classes and species for cwCF. Matched metagenomic analysis suggests possible defects in both host intestinal BA absorption and gut microbial BA metabolism. Additional analyses of mouse and ferret CF stool for BA composition suggest great care must be taken when interpreting BA functional studies using these animal models. Together, this work lays technical and conceptual foundations for interrogating BA-microbe interactions in cwCF.

Indexed as

Bile Acids and SaltsCystic FibrosisFecesAnimalsBacteroidetesChildDisease Models, AnimalDysbiosisFemaleFerretsHumansIntestinal AbsorptionMaleMiceMice, Inbred C57BLMicrobiotaBile Acids and Saltsbile acidscystic fibrosisferrethumanmouse

Identifiers

PMID40956094
PMCPMC12502738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.